Boston Scientific's earnings growth may slow to the low teens, making current P/E multiples hard to justify. See why BSX ...

Global Vascular Boot Market is valued at approximately USD 1.13 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 3.26 % over the forecast period 2024-2032. Read the ...

Industrial Analysis of Coronary Stent in India value of over USD 1,213.5 million by 2033 anticipated expansion is supported ...

The vascular stents market is anticipated to grow from USD 11.4 billion in 2024 to USD 15.6 billion by 2029, with a CAGR of 6.5%. This growth ...

DELRAY BEACH, Fla. , Sept. 12, 2024 /PRNewswire/ -- The vascular stents market is anticipated to grow from USD 11.4 billion ...

Boston Scientific (NYSE:BSX) issued an urgent field safety notice to warn of a software anomaly with its Avvigo+ guidance ...

Global Interventional Neurology Devices Market is valued approximately USD 2.6 billion in 2023 and is anticipated to grow with a growth rate of more than 4.70% over the forecast period 2024-2032. Read ...

Oshae Brissett is coming off a year where he appeared in 55 games for the Boston Celtics. He finished the season with averages of 3.7 points and 2.9 rebounds per contest while shooting 44.4% from ...

Boston Scientific Corporation ( NYSE: BSX) Wells Fargo 2024 Healthcare Conference September 4, 2024 8:00 AM ET Brad Sutton - Chief Medical Officer, AF Solutions Jon Monson - SVP, IR Michael F. Mahoney ...

But there’s a powerful fundamental story happening with Boston Scientific. Also, EPS is estimated to ramp higher this year by +13.3%. Now it makes sense why the stock has been powering to new ...